PCI has focused on becoming a trusted CDMO partner by building strong working relationships with clients.

What happened in April in the biopharma industry? Here’s our roundup of the biggest headlines and research.

In our second C+G Champions installment, we ask industry leaders in the cell and gene field to answer key questions about the industry.

What will drug development look like aboard a new commercial space station?

Advanced analytical technologies now offer the detailed assessments biopharma drug developers need.

What do companies need to consider when developing next-gen medicines for rare diseases?

The COVID-19 pandemic exposed weaknesses in pharma supply chains. It’s time to address these.

This 6 episode miniseries will take listeners behind the scenes of a range of projects at the Drugs for Neglected Diseases initiative

How can multi-column chromatography support companies as they set their sights on intensified bioprocesses?

Is commercializing gene therapy manufacturing an unsolvable problem? We ask an expert on the frontlines.